SEC 13F Intelligence

Managers / Q1 2025 · view latest →

Forefront Analytics, LLC

CIK 0001696802 · ONE TOWER BRIDGE, 100 FRONT STREET, SUITE 1111, WEST CONSHOHOCKEN, PA, 19428 · 6103413900

Reported Value
$87M
Q1 2025
Positions
72
Filings on Record
31
2019–present window
Filed
May 13, 2025
original filing

Summary

Forefront Analytics, LLC reported $87M in U.S.-listed holdings across 72 positions for Q1 2025.

The portfolio is heavily concentrated: Nushares Etf Tr alone accounts for 25.9% of reported value.

Compared with Q4 2024, the fund opened 2 new positions and exited 21.

Portfolio Metrics

Turnover
+5.2%
vs prior filed quarter
Top-10 Concentration
+78.5%
share of reported value
Largest Position
+25.9%
Nushares Etf Tr
New / Exited
2 / 21
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $181MQ4 ’18Q1 ’19: $157MQ2 ’19: $235MQ3 ’19: $243MQ4 ’19: $257MQ4 ’19Q3 ’20: $214MQ4 ’20: $230MQ1 ’21: $235MQ2 ’21: $252MQ2 ’21Q3 ’21: $274MQ4 ’21: $299MQ1 ’22: $269MQ2 ’22: $206MQ2 ’22Q3 ’22: $188MQ4 ’22: $188MQ1 ’23: $194MQ2 ’23: $175MQ2 ’23Q3 ’23: $176MQ4 ’23: $203MQ1 ’24: $206MQ2 ’24: $209MQ2 ’24Q3 ’24: $212MQ4 ’24: $215MQ1 ’25: $87MQ2 ’25: $90MQ2 ’25Q3 ’25: $104MQ4 ’25: $113MQ1 ’26: $110Mfilingsflow.com

Portfolio Composition

By security type
ETP: 93.2%Common Stock: 5.9%Other: 0.6%ADR: 0.4%
  • ETP · 93.2% · $81M
  • Common Stock · 5.9% · $5M
  • Other · 0.6% · $481,513
  • ADR · 0.4% · $325,836

Quarter-over-Quarter Changes full breakdown →

vs Q4 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
4I1PHILIP MORRIS INTL INCNEW+1.4K1.4K+$222,000$222,000
LEGNLEGEND BIOTECH CORPNEW+6.4K6.4K+$218,564$218,564
GONGERON CORPADDED+44.0K63.0K+$32,610$99,951
ZURA BIO LTDADDED+54.6K108.3K+$5,464$139,801
VANGUARD CHARLOTTE FDSSOLD OUT318.1K0$16M$0
ISHARES TRSOLD OUT147.4K0$13M$0
AOKISHARES TRSOLD OUT347.3K0$13M$0
SPDR SER TRSOLD OUT217.6K0$8M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2025

34 positions
#IssuerClass% PortfolioValueShares
1NUSHARES ETF TRNUVEEN ESG LRGVL25.85%$22M555.0K
2ISHARES TRMSCI USA MMENTM · CORE HIGH DV ETF · MSCI USA MIN VOL · CORE S&P500 ETF · MSCI INDIA ETF · GLB INFRASTR ETF · TIPS BD ETF · 3 7 YR TREAS BD · 7-10 YR TRSY BD25.29%$22M155.9K
3SPDR SER TRSPDR S&P 500 ETF10.73%$9M203.9K
4VANGUARD INTL EQUITY INDEX FFTSE EMR MKT ETF8.17%$7M156.9K
5VANGUARD TAX-MANAGED FDSVAN FTSE DEV MKT6.39%$6M109.3K
6DBX ETF TRXTRACK MSCI EAFE5.34%$5M107.2K
7VTVVANGUARD INDEX FDSVALUE ETF · SMALL CP ETF3.93%$3M18.6K
8ISHARES INCCUR HD MSCI EM2.07%$2M64.0K
9NVDANVIDIA CORPORATIONhistory →COM1.85%$2M14.9K
10SPDR S&P 500 ETF TRTR UNIT1.76%$2M2.7K
11WISDOMTREE TRUS SMALLCAP FUND1.46%$1M26.0K
12JPMJPMORGAN CHASE & CO.COM0.93%$810,0003.3K
13PROSHARES TRPSHS ULT S&P 500 · PSHS ULTRUSS20000.69%$598,36911.9K
14DEDEERE & COCOM0.61%$527,0001.1K
15FIRST TR EXCHANGE-TRADED FDNO AMER ENERGY0.57%$498,00013.3K
16PIMCO ETF TR15+ YR US TIPS0.47%$405,0007.4K
17UNHUNITEDHEALTH GROUP INCCOM0.45%$392,813750
18EWEDWARDS LIFESCIENCES CORPCOM0.38%$333,9154.6K
19MEDTRONIC PLCSHS0.29%$250,9462.8K
20TMOTHERMO FISHER SCIENTIFIC INCCOM0.26%$225,596453
214I1PHILIP MORRIS INTL INCCOM0.26%$222,0001.4K
22BARCLAYS BANK PLCDJUBS CMDT ETN360.25%$216,0006.1K
23LEGNLEGEND BIOTECH CORPSPONSORED ADS0.24%$204,5646.0K
24PFEPFIZER INCCOM0.23%$203,7838.0K
25INVESCO EXCH TRADED FD TR IISR LN ETF0.23%$203,0009.8K
26INCYINCYTE CORPCOM0.22%$189,6433.1K
27ZURA BIO LTDCLASS A ORD SHS0.15%$129,801100.6K
28MREOMEREO BIOPHARMA GROUP PLCSPON ADS0.11%$99,27244.1K
29GONGERON CORPCOM0.11%$92,95158.5K
30COGTCOGENT BIOSCIENCES INCCOM0.09%$77,48712.9K
31IMMATICS N.VSHS0.08%$66,76614.8K
322662247DITEOS THERAPEUTICS INCCOM0.07%$61,36610.3K
33CTMXCYTOMX THERAPEUTICS INCCOM0.07%$59,14193.0K
34ANNXANNEXON INCCOM0.06%$51,32626.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$110M39May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$113M47Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$104M46Nov 21, 202513F-HRchanges · EDGAR ↗
Q2 2025$90M47Aug 14, 2025RESTATEMENTchanges · EDGAR ↗
Q1 2025$87M72May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$215M113Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$212M114Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$209M114Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$206M113May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$203M112Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$176M67Nov 8, 202313F-HRchanges · EDGAR ↗
Q2 2023$175M115Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$194M138May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$188M130Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$188M115Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$206M114Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$269M119May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$299M109Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$274M118Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$252M113Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$235M114May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$230M109Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$214M98Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020Under review92Aug 10, 202013F-HRchanges · EDGAR ↗
Q1 2020Under review179May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$257M77Feb 5, 202013F-HRchanges · EDGAR ↗
Q3 2019$243M76Nov 5, 201913F-HRchanges · EDGAR ↗
Q2 2019$235M69Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$157M69May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$181M73Feb 12, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • GKFO LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.